Clinical Trial Update: Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia [Phase 2]

View source ↗

Summary

A Phase 2 exploratory clinical trial evaluating the digital therapeutic device Zenicom for subacute stroke-related aphasia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Drugs mentioned

• Zenicom

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Aphasia, Stroke | Phase 2 | Status: RECRUITING